Insights

Niche Market Focus BioPharmX specializes in developing dermatologic treatments for chronic conditions like rosacea and acne, presenting targeted sales opportunities with dermatology clinics, specialist dermatologists, and skincare providers seeking innovative therapies.

Growing Industry Demand The company's focus on dermatological solutions aligns with increasing consumer and healthcare demand for effective, non-invasive skin treatment options, opening avenues for partnerships with dermatology-focused healthcare entities and pharmaceutical distributors.

Product Development Pipeline With two lead products in development, there is potential to collaborate on clinical trials, licensing, or distribution agreements, especially with clinics and hospitals eager to adopt new dermatology treatments.

Strategic Leadership Recent leadership appointments, including experienced industry veterans, enhance BioPharmX’s credibility and market positioning, making it an attractive partner for joint ventures or co-marketing efforts in dermatology markets.

Financial Opportunities Though revenue is modest, BioPharmX’s funding and pipeline suggest potential for growth; engaging with investment or licensing opportunities could be beneficial for expanding distribution channels and accelerating product adoption.

BioPharmX Tech Stack

BioPharmX uses 8 technology products and services including WordPress, Twemoji, Google Fonts API, and more. Explore BioPharmX's tech stack below.

  • WordPress
    Content Management System
  • Twemoji
    Font Scripts
  • Google Fonts API
    Font Scripts
  • jQuery UI
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Google Maps
    Maps
  • New Relic
    Real User Monitoring
  • Adobe Fonts
    Web Fonts

BioPharmX's Email Address Formats

BioPharmX uses at least 1 format(s):
BioPharmX Email FormatsExamplePercentage
FLast@biopharmx.comJDoe@biopharmx.com
58%
Last@biopharmx.comDoe@biopharmx.com
42%

Frequently Asked Questions

What is BioPharmX's phone number?

Minus sign iconPlus sign icon
You can contact BioPharmX's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioPharmX's stock symbol?

Minus sign iconPlus sign icon
BioPharmX is a publicly traded company; the company's stock symbol is TMBRQ.

What is BioPharmX's official website and social media links?

Minus sign iconPlus sign icon
BioPharmX's official website is biopharmx.com and has social profiles on LinkedInCrunchbase.

What is BioPharmX's SIC code NAICS code?

Minus sign iconPlus sign icon
BioPharmX's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioPharmX have currently?

Minus sign iconPlus sign icon
As of July 2026, BioPharmX has approximately 4 employees across 1 continents, including North America. Key team members include Co-Founder And Executive Vp R&d/Technology: K. C.Senior Director: U. N.. Explore BioPharmX's employee directory with LeadIQ.

What industry does BioPharmX belong to?

Minus sign iconPlus sign icon
BioPharmX operates in the Biotechnology Research industry.

What technology does BioPharmX use?

Minus sign iconPlus sign icon
BioPharmX's tech stack includes WordPressTwemojiGoogle Fonts APIjQuery UIModernizrGoogle MapsNew RelicAdobe Fonts.

What is BioPharmX's email format?

Minus sign iconPlus sign icon
BioPharmX's email format typically follows the pattern of FLast@biopharmx.com. Find more BioPharmX email formats with LeadIQ.

How much funding has BioPharmX raised to date?

Minus sign iconPlus sign icon
As of July 2026, BioPharmX has raised $20M in funding. The last funding round occurred on Mar 18, 2015 for $7.9M.

When was BioPharmX founded?

Minus sign iconPlus sign icon
BioPharmX was founded in 2011.
BioPharmX logo

BioPharmX

Biotechnology ResearchCalifornia, United States2-10 Employees

BioPharmX is a biotechnology company based in San Jose, California. It concentrates on developing prescription dermatology products for chronic skin conditions that are not adequately addressed by existing therapies. The company utilizes a proprietary HyantX delivery system to support dermatology applications. Its development pipeline includes BPX-04 for papulopustular rosacea and BPX-01 for acne vulgaris.

The firm operates as a small biotechnology company within the dermatology segment of the industry and is listed on the NYSE American under the ticker BPMX. In 2019 BioPharmX announced the appointment of Steven M. Bosacki as Chief Operating Officer, a leadership move noted in company events.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
TMBRQ
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
2-10

Section iconFunding & Financials

  • $20M

    BioPharmX has raised a total of $20M of funding over 3 rounds. Their latest funding round was raised on Mar 18, 2015 in the amount of $7.9Mas a series_a.

  • $1M$10M

    BioPharmX's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $20M

    BioPharmX has raised a total of $20M of funding over 3 rounds. Their latest funding round was raised on Mar 18, 2015 in the amount of $7.9Mas a series_a.

  • $1M$10M

    BioPharmX's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.